The Canadian government has created a unique legal framework that will now enable the research (and eventual manufacturing) of cannabis finished products.
Initially, in late 2018 cannabis cosmetics will be the first category of finished products permitted, alongside any pharmaceutical cannabis products that have a Drug Identification Number from the Therapeutic Products Directorate. Edibles and concentrates are currently not permitted, but Cannabis Compliance Inc is participating in government consultations around their eventual regulatory framework. It is expected that regulations around edibles and concentrates would be introduced in early 2019 and coming into force by October of 2019. Cannabis health products – e.g., natural health products containing cannabinoids – were initially discussed in the new framework as it was under development, but which are not being permitted under the current Cannabis Regulations; it is possible they will be permitted alongside the introduction of edibles and concentrates in late 2019.
Currently, aside from cannabis cosmetics and cannabis pharmaceuticals, only the dried flower and cannabis oil (liquid or soft gels) are permitted for production. To manufacture cannabis oil (liquid or soft gels), a facility has to be in possession of a Micro or Standard Processor Licence. Down the road, it is proposed that this same type of processing licence would be required to manufacture edibles, concentrates and cannabis health products, however this is yet to be determined. Essentially, the Micro and Standard Processor Licences are required to manufacture cannabis oil.
In the past several years, companies desiring to conduct research with various cannabis derivatives and delivery vehicles, were required to do so under a Dealer’s Licence (DL) under the Narcotic Control Regulations. Many licensed producers have achieved both a Production Licence (under the former ACMPR) as well as a Dealer’s Licence. However, the DL will no longer be the facility licence authorizing cannabis research and development. In its place, a Research and Development Licence will now authorize companies to experiment with creating unique finished products strictly for research (not resale) purposes ahead of future regulations permitting their sale.
The following pages in this section discuss the various types of finished products that are slated to be legalized in the year or two ahead and providing a pathway for companies to begin formulating and developing such products.